Sam Dychter, MD, FFPM, is currently a Global Development Lead at Pfizer Oncology, leveraging over 25 years of international experience in medical and drug development across oncology and immunology. Previously, Sam has held key roles such as Executive Medical Director at Halozyme Therapeutics, Clinical Program Leader at Pfizer, and Associate Medical Director at Chugai Pharma USA. Sam’s academic involvement includes serving as a lecturer at the University of California San Diego and being a member of the Board of Advisors for the Institute of the Americas. Sam earned their Doctor of Medicine degree from the Universidad Nacional Autónoma de México.
This person is not in any teams
This person is not in any offices